Detalles de la búsqueda
1.
Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
Lipids Health Dis
; 19(1): 114, 2020 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466791
2.
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Pharmaceuticals (Basel)
; 16(1)2022 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36678541
3.
Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
Curr Pharm Des
; 27(21): 2537-2544, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593250
4.
An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Hormones (Athens)
; 16(3): 306-312, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30091117
5.
An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Hormones (Athens)
; 16(3): 200-204, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29278517
6.
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Hormones (Athens)
; 15(1): 8-14, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27086681
7.
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
Angiology
; 63(5): 358-66, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22007026
8.
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.
Curr Vasc Pharmacol
; 9(6): 647-57, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21476961
Resultados
1 -
8
de 8
1
Próxima >
>>